Cargando…

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending

POLICY POINTS: Our study indicates that there are opportunities for cost savings in generic drug markets in Europe and the United States. Regulators should make it easier for generic drugs to reach the market. Regulators and payers should apply measures to stimulate price competition among generic d...

Descripción completa

Detalles Bibliográficos
Autores principales:	WOUTERS, OLIVIER J., KANAVOS, PANOS G., McKEE, MARTIN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594322/ https://www.ncbi.nlm.nih.gov/pubmed/28895227 http://dx.doi.org/10.1111/1468-0009.12279

Ejemplares similares

A comparison of generic drug prices in seven European countries: a methodological analysis
por: Wouters, Olivier J., et al.
Publicado: (2017)

The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors
por: von der Schulenburg, Fritz, et al.
Publicado: (2011)

Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
por: Kamphuis, Bregtje W., et al.
Publicado: (2021)

Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition
por: Dickson, Sean R., et al.
Publicado: (2021)

Generic Medicine Pricing Policies in Europe: Current Status and Impact
por: Dylst, Pieter, et al.
Publicado: (2010)

Understanding Differences in Health Care Spending: A Comparative Study of Prices and Volumes Across OECD Countries
por: Lorenzoni, Luca, et al.
Publicado: (2022)

The long-term effect of generic price competition on the Hungarian statin market
por: Répásy, Balázs, et al.
Publicado: (2023)

The effect of generic market entry on antibiotic prescriptions in the United States
por: Kållberg, Cecilia, et al.
Publicado: (2021)

Erratum to Understanding Differences in Health Care Spending: A Comparative Study of Prices and Volumes Across OECD Countries
Publicado: (2022)

An empirical study of the impact of generic drug competition on drug market prices in China
por: Yina, Chen, et al.
Publicado: (2023)

Trends in Prices of Popular Brand-Name Prescription Drugs in the United States
por: Wineinger, Nathan E., et al.
Publicado: (2019)

The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China
por: Zhang, Yichen, et al.
Publicado: (2021)

Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Association of State Medicaid Expansion With Hospital Community Benefit Spending
por: Kanter, Genevieve P., et al.
Publicado: (2020)

State Public Assistance Spending and Survival Among Adults With Cancer
por: Barnes, Justin M., et al.
Publicado: (2023)

Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018
por: Wouters, Olivier J.
Publicado: (2020)

New pricing models for generic medicines to ensure long-term sustainable competition in Europe
por: Francois, Clement, et al.
Publicado: (2023)

Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD Countries
por: Mills, Mackenzie, et al.
Publicado: (2023)

Analysis of the evolution of the price of oncology drugs after the loss of their patent and the marketing of generic medicines
por: Martínez-Sesmero, José M., et al.
Publicado: (2022)

Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform
por: Wouters, Olivier J, et al.
Publicado: (2015)

Price dispersion of generic medications
por: Bernstein, John J. J., et al.
Publicado: (2019)

The impact of generics and generic reference pricing on candesartan and rosuvastatin utilisation, price and expenditure in South Africa
por: de Jager, Henk, et al.
Publicado: (2018)

Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?
por: Trujillo, Antonio J., et al.
Publicado: (2022)

Who initiates price competition when generic entrants are introduced into the South Korean pharmaceutical market?
por: Son, Kyung-Bok
Publicado: (2022)

Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018
por: Alpern, Jonathan D., et al.
Publicado: (2020)

Does external reference pricing deliver what it promises? Evidence on its impact at national level
por: Kanavos, Panos, et al.
Publicado: (2019)

Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
por: Dusetzina, Stacie B., et al.
Publicado: (2021)

Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry
por: Zhou, Edward W., et al.
Publicado: (2023)

Market Prices
por: Beecher, Thos. K.
Publicado: (1885)

State Tobacco Control Program Spending — United States, 2011
por: Huang, Jidong, et al.
Publicado: (2015)

Assessment of Spending for Patients Initiating Dialysis Care
por: League, Riley J., et al.
Publicado: (2022)

Spending on and Use of Clinician-Administered Drugs in Medicare
por: Hyland, Megan F., et al.
Publicado: (2023)

Analysis of the Korean generic medicine market: Factors affecting the market share of generic medicines
por: Kim, Dong‐Sook, et al.
Publicado: (2021)

An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012
por: Lee, Janice Soo Fern, et al.
Publicado: (2016)

Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs
por: Mattingly, T. Joseph, et al.
Publicado: (2023)

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland
por: Martikainen, Jaana E, et al.
Publicado: (2015)

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
por: Docteur, Elizabeth, et al.
Publicado: (2015)

Effect of Prices, Distribution Strategies, and Marketing on Demand for HIV Self-testing in Zimbabwe: A Randomized Clinical Trial
por: Chang, Wei, et al.
Publicado: (2019)

Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors
por: Spillane, Susan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vhn9ca374d8kp6hfug74gc1g63